000 01389 a2200349 4500
005 20250515034258.0
264 0 _c20061002
008 200610s 0 0 eng d
022 _a0065-1427
024 7 _a10.1111/j.1600-0404.2006.00680.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaskowitz, D T
245 0 0 _aApolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease.
_h[electronic resource]
260 _bActa neurologica Scandinavica. Supplementum
_c2006
300 _a15-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aApolipoprotein E4
650 0 4 _aApolipoproteins E
_xphysiology
650 0 4 _aBlood-Brain Barrier
_xphysiopathology
650 0 4 _aHumans
650 0 4 _aLow Density Lipoprotein Receptor-Related Protein-1
_xphysiology
650 0 4 _aNervous System Diseases
_xetiology
650 0 4 _aNeurogenic Inflammation
_xetiology
650 0 4 _aNeuroglia
_xphysiology
650 0 4 _aPeptide Fragments
_xphysiology
700 1 _aFillit, H
700 1 _aYeung, N
700 1 _aToku, K
700 1 _aVitek, M P
773 0 _tActa neurologica Scandinavica. Supplementum
_gvol. 185
_gp. 15-20
856 4 0 _uhttps://doi.org/10.1111/j.1600-0404.2006.00680.x
_zAvailable from publisher's website
999 _c16456383
_d16456383